-
Product Insights
NewPolyomavirus Infections – Drugs In Development, 2024
Empower your strategies with our Polyomavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Polyomaviruses, a family of small DNA viruses, pose potential threats to human health. Among them, the BK virus (BKV) and JC virus (JCV) are known to infect humans, with implications for those with weakened immune systems. While these viruses can circulate without symptoms in the general population, immunocompromised individuals face complications. BKV may induce nephropathy or cystitis, particularly in organ transplant recipients....
-
Product Insights
NewProgressive Multifocal Leukoencephalopathy – Drugs In Development, 2024
Empower your strategies with our Progressive Multifocal Leukoencephalopathy – Drugs In Development, 2024 report and make more profitable business decisions. Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by lytic infection of oligodendrocytes by polyomavirus, also known as JC (John Cunningham) virus. Symptoms include clumsiness, progressive weakness, and visual, speech, and sometimes personality changes. Risk factors include the presence of pathogenic JC virus and an altered or weakened immune system, and genetic or environmental factors. The Progressive...